Abbott Molecular

Abbott Molecular — FDA 510(k) Submissions

Abbott Molecular has submitted 2 FDA 510(k) premarket notifications since 2024, of which 2 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Respiratory Specimen Nucleic Acid Sars-cov-2 Test, System For Detection Of Nucleic Acid From Non-viral Microorganism(s) Causing Stis Using Specimens Collected At Home . Use the specialty filter in the sidebar to narrow results.